4DMedical Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Andreas Fouras

Chief executive officer

AU$988.1k

Total compensation

CEO salary percentage56.4%
CEO tenureno data
CEO ownership0.2%
Management average tenure1.8yrs
Board average tenure5.3yrs

Recent management updates

4DMedical Limited's (ASX:4DX) CEO Compensation Is Looking A Bit Stretched At The Moment

Oct 26
4DMedical Limited's (ASX:4DX) CEO Compensation Is Looking A Bit Stretched At The Moment

Recent updates

4DMedical Limited's (ASX:4DX) CEO Compensation Is Looking A Bit Stretched At The Moment

Oct 26
4DMedical Limited's (ASX:4DX) CEO Compensation Is Looking A Bit Stretched At The Moment

Here's Why We're Not At All Concerned With 4DMedical's (ASX:4DX) Cash Burn Situation

Jun 16
Here's Why We're Not At All Concerned With 4DMedical's (ASX:4DX) Cash Burn Situation

We Think 4DMedical (ASX:4DX) Needs To Drive Business Growth Carefully

Feb 01
We Think 4DMedical (ASX:4DX) Needs To Drive Business Growth Carefully

Is 4DMedical (ASX:4DX) In A Good Position To Deliver On Growth Plans?

Oct 18
Is 4DMedical (ASX:4DX) In A Good Position To Deliver On Growth Plans?

We're Hopeful That 4DMedical (ASX:4DX) Will Use Its Cash Wisely

Jul 05
We're Hopeful That 4DMedical (ASX:4DX) Will Use Its Cash Wisely

We Think 4DMedical (ASX:4DX) Can Afford To Drive Business Growth

Jan 27
We Think 4DMedical (ASX:4DX) Can Afford To Drive Business Growth

Here's Why We're Not Too Worried About 4DMedical's (ASX:4DX) Cash Burn Situation

Jun 05
Here's Why We're Not Too Worried About 4DMedical's (ASX:4DX) Cash Burn Situation

Is 4DMedical Limited's (ASX:4DX) Shareholder Ownership Skewed Towards Insiders?

Feb 20
Is 4DMedical Limited's (ASX:4DX) Shareholder Ownership Skewed Towards Insiders?

CEO Compensation Analysis

How has Andreas Fouras's remuneration changed compared to 4DMedical's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-AU$31m

Sep 30 2023n/an/a

-AU$31m

Jun 30 2023AU$988kAU$557k

-AU$31m

Mar 31 2023n/an/a

-AU$30m

Dec 31 2022n/an/a

-AU$28m

Sep 30 2022n/an/a

-AU$26m

Jun 30 2022AU$821kAU$519k

-AU$25m

Mar 31 2022n/an/a

-AU$23m

Dec 31 2021n/an/a

-AU$21m

Sep 30 2021n/an/a

-AU$21m

Jun 30 2021AU$646kAU$502k

-AU$21m

Mar 31 2021n/an/a

-AU$26m

Dec 31 2020n/an/a

-AU$30m

Sep 30 2020n/an/a

-AU$26m

Jun 30 2020AU$1mAU$435k

-AU$22m

Mar 31 2020n/an/a

-AU$16m

Dec 31 2019n/an/a

-AU$9m

Sep 30 2019n/an/a

-AU$8m

Jun 30 2019AU$366kAU$360k

-AU$6m

Compensation vs Market: Andreas's total compensation ($USD649.51K) is about average for companies of similar size in the Australian market ($USD632.64K).

Compensation vs Earnings: Andreas's compensation has increased whilst the company is unprofitable.


CEO

Andreas Fouras

no data

Tenure

AU$988,105

Compensation

Dr. Andreas Fouras, BEng, MEngSc(Res), Ph.D. M.A.I.C.D. is Founder of 4DMedical Limited and serves as its Managing Director, Chief Executive Officer & Director and served as its Chief Technology Officer. D...


Leadership Team

NamePositionTenureCompensationOwnership
Andreas Fouras
Founderno dataAU$988.11k0.22%
A$ 513.8k
Simon Glover
Chief Financial Officer1.8yrsAU$360.91kno data
John Livingston
Executive Director2yrsAU$297.18k0.49%
A$ 1.1m
Naomi Lawrie
Company Secretary & General Counsel1.1yrsno datano data
Rachael Tenkaten
Chief of Staff1.8yrsno datano data
Aidan Jamison
Senior Vice President of Engineeringno datano datano data
Michael Curtis
Chief Software Architectno datano datano data
Jon Dusting
Chief Research Officer1.8yrsno datano data
Jason Kirkness
Senior Vice President of Medical & Clinical Affairs1.8yrsno datano data
Matt Tucker
Chief Commercial Officer1.4yrsno datano data
Greg Mogel
Senior VP & Executive Medical Directorno datano datano data

1.8yrs

Average Tenure

Experienced Management: 4DX's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Andreas Fouras
Founderno dataAU$988.11k0.22%
A$ 513.8k
John Livingston
Executive Director6.2yrsAU$297.18k0.49%
A$ 1.1m
Sam Hupert
Member of Advisory Board5.3yrsno datano data
Robert Figlin
Independent Non-Executive Director7.4yrsAU$63.20k0.13%
A$ 309.4k
Julian Sutton
Non-Executive Director6.7yrsAU$217.60k0.12%
A$ 286.1k
Raymond Casciari
Clinical Chair of the Advisory Board5yrsno datano data
Lilian Bianchi
Independent Non-Executive Chair4.4yrsAU$78.20k0.024%
A$ 55.5k
Bruce Thompson
Member of Advisory Boardno datano datano data
Geraldine McGinty
Independent Non-Executive Directorless than a yearno data0.010%
A$ 23.8k

5.3yrs

Average Tenure

Experienced Board: 4DX's board of directors are considered experienced (5.3 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.